About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Arizona | 16,608 Studies Near You

Clinical TrialsArizona

Clinical Trials in Arizona

Discover 16,608 clinical trials near Arizona. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 2961-2980 of 16,608 trials

TerminatedConfirmatory Study of Topical HyBryte™ vs. Placebo for the Treatment of CTCLTo evaluate the use of HyBryte, a topical photosensitizing agent, to treat patients with patch/plaque phase cutaneous T-cell lymphoma (mycosis fungoides).NCT06470451·Phoenix, Arizona and 16 others CompletedA Safety and Efficacy Study of ADS-5102 in Patients With Multiple Sclerosis and Walking ImpairmentThis study assessed the long-term safety and tolerability of ADS-5102 in subjects with MS and walking impairment who had completed the double-blind, placebo-controlled study of…NCT03567057·Cullman, Alabama and 91 others

Find Trials by Condition in Arizona

Breast Cancerin Arizona Lung Cancerin Arizona Prostate Cancerin Arizona Colorectal Cancerin Arizona Melanomain Arizona Leukemiain Arizona Lymphomain Arizona Pancreatic Cancerin Arizona Ovarian Cancerin Arizona Brain Cancerin Arizona Diabetes

Data from ClinicalTrials.govTerms

UnknownA Study of ICP-192 in Patients With Advanced Solid TumorsThis is a multi-center, open-label, phase I/II clinical study to evaluate ICP-192 in patients with advanced solid tumors and FGFR gene alterations.NCT04565275·Tucson, Arizona and 15 others

CompletedPersonal KinetiGraph® Clinical Validation StudyThe purpose of this study is to clinically validate new measures of the Personal KinetiGraph® (PKG®).NCT05251701·Tucson, Arizona

CompletedMild and Rapidly Improving Stroke StudyThe objective of this study is to determine the 90-day outcomes of mild and rapidly improving ischemic stroke.NCT02072681·Chandler, Arizona and 96 others

CompletedLedipasvir/Sofosbuvir Fixed-Dose Combination + Ribavirin in Subjects With Chronic HCV With Advanced Liver Disease or Post-Liver TransplantThis study will evaluate ledipasvir/sofosbuvir (LDV/SOF) fixed-dose combination (FDC) plus ribavirin (RBV) in participants with advanced liver disease or posttransplant and…NCT01938430·Phoenix, Arizona and 29 others

RecruitingEvaluating the Association Among Changes in Gut Microbiome, Fatigue, and Chemotherapy-Induced Nausea in Early Stage Breast CancerThis pilot study seeks to understand how changes in the bacteria composition (microbiome) of the gut may be associated with the occurrence of fatigue and chemotherapy-induced…NCT05417867·Scottsdale, Arizona and 4 others

TerminatedRadiation Therapy or Observation After Chemotherapy in Treating Patients With Stage IV Non-Small Cell Lung CancerRATIONALE: Radiation therapy uses high-energy x-rays to kill tumor cells. Sometimes, after chemotherapy, the tumor may not need more treatment until it progresses.NCT00776100·Scottsdale, Arizona and 167 others

CompletedObservational Registry Study of Quality of Life When Treating BTcP With AbstralThis Observational Registry study is designed to collect self-reported Transmucosal Immediate Release Fentanyl (TIRF) Risk Evaluation and Mitigation Strategy (REMS) Access…NCT01936636·Mobile, Alabama and 35 others

CompletedPhase 2b, Open-label, Multicenter, Rollover Study to Assess Antiviral Activity and Safety of Long-acting (LA) Cabotegravir (CAB) Plus LA Rilpivirine (RPV), Administered Every 2 Months (Q2M), in Human Immunodeficiency Virus (HIV)-Positive Participants From the LATTE StudyThis study (POLAR), is designed to assess the antiviral activity and safety of CAB LA plus RPV LA, administered Q2M, in approximately 100 adult HIV-1 infected, antiretroviral…NCT03639311·Phoenix, Arizona and 29 others

TerminatedAssessment and Tracking of Long-term Alefacept SafetySubjects exposed to alefacept are to be enrolled. Subjects will be contacted every 6 months to gather general health information.NCT00454701·Birmingham, Alabama and 267 others

CompletedA Study of LY2623091 in Participants With High Blood PressureThe main purpose of this study is to evaluate the safety and effectiveness of the study drug known as LY2623091 in participants with high blood pressure.NCT02194465·Glendale, Arizona and 42 others

CompletedCerebral Hemorrhage Risk in Hereditary Hemorrhagic TelangiectasiaThis study is one of the three projects of an NIH Rare Disease Clinical Research Consortium.NCT01158807·Phoenix, Arizona and 18 others

CompletedA Study of the Efficacy and Safety of EP-101 ( (SUN101) in Subjects With Moderate to Severe Chronic Obstructive Pulmonary DiseaseThis is a randomized, double-blind, placebo-controlled, parallel arm study.NCT01706536·Jasper, Alabama and 25 others

TerminatedPivotal Clinical Study of Endoscopic Ablation for Atrial Fibrillation (AF) in Patients That Have Failed DrugsThe purpose of the study is to compare two types of treatment for atrial fibrillation (AF) that are designed to treat the symptoms of atrial fibrillation.NCT00477230·Scottsdale, Arizona and 17 others

CompletedA Study of PRT-201 Administered Immediately After Radiocephalic Arteriovenous Fistula(AVF) Creation in Patients With Chronic Kidney Disease (CKD) (PATENCY-1)This research study is designed to assess the safety and effectiveness of an experimental drug called PRT-201 in patients both receiving or expecting to receive dialysis who have…NCT02110901·Birmingham, Alabama and 34 others

Completed8 Weeks Treatment With DDP225 in Patients With Diarrhea Predominant IBSIn this study, female patients with IBS-d will be treated for 8 weeks to assess the safety and effectiveness of DDP225 on GI transit and in reducing IBS symptoms.NCT00230581·Scottsdale, Arizona and 15 others

CompletedA Phase 2b, Randomized, Double-blind, Active-controlled Study of Single Dose CVXGA Intranasal COVID-19 Vaccine in AdultsThe purpose of this trial is to assess the safety and relative efficacy of CVXGA (CVXGA50), a KP.2 containing vaccine, compared to COMIRNATY® (COVID-19 Vaccine, mRNA; 2024-2025…NCT06742281·Anniston, Alabama and 54 others

CompletedEfficacy and Safety of AMG 570 in Subjects With Active Systemic Lupus Erythematosus (SLE)The purpose of this study is to determine if Rozibafusp Alfa could be a useful therapeutic agent in the current treatment landscape where subjects with SLE have ongoing disease…NCT04058028·Birmingham, Alabama and 146 others

CompletedSustainability Via Active Garden EducationThe goal of SAGE is to determine if a garden-based curriculum can increase physical activity and improve nutrition in young children at early care and education centers (ECEC)…NCT03261492·Phoenix, Arizona

PreviousPage 149 of 831Next

in Arizona

Heart Diseasein Arizona